Skip to results
Modify your search
NARROW
1-10 of 10
Authors: Clark C Chen
Sort by
Journal Article
Combined immunotherapy with controlled interleukin-12 gene therapy and immune checkpoint blockade in recurrent glioblastoma: An open-label, multi-institutional phase I trial Free
E Antonio Chiocca and others
Neuro-Oncology, Volume 24, Issue 6, June 2022, Pages 951–963, https://doi.org/10.1093/neuonc/noab271
Published: 26 November 2021
Journal Article
LTBK-04. PHASE 2 MULTICENTER STUDY OF THE ONCOLYTIC ADENOVIRUS DNX-2401 (TASADENOTUREV) IN COMBINATION WITH PEMBROLIZUMAB FOR RECURRENT GLIOBLASTOMA; CAPTIVE STUDY (KEYNOTE-192) Free
Gelareh Zadeh and others
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii237, https://doi.org/10.1093/neuonc/noaa215.989
Published: 20 November 2020
Journal Article
Epidermal growth factor receptor as a molecular determinant of glioblastoma response to dopamine receptor D2 inhibitors Free
Yuyu He and others
Neuro-Oncology, Volume 23, Issue 3, March 2021, Pages 400–411, https://doi.org/10.1093/neuonc/noaa188
Published: 24 August 2020
Journal Article
EDITOR'S CHOICE
Durable complete responses in some recurrent high-grade glioma patients treated with Toca 511 + Toca FC Free
Timothy F Cloughesy and others
Neuro-Oncology, Volume 20, Issue 10, October 2018, Pages 1383–1392, https://doi.org/10.1093/neuonc/noy075
Published: 12 May 2018
Journal Article
Mapping of genomic EGFRvIII deletions in glioblastoma: insight into rearrangement mechanisms and biomarker development Free
Tomoyuki Koga and others
Neuro-Oncology, Volume 20, Issue 10, October 2018, Pages 1310–1320, https://doi.org/10.1093/neuonc/noy058
Published: 12 April 2018
Journal Article
DDEL-06PRELIMINARY SAFETY OF TOCA 511, A RETROVIRAL REPLICATING VECTOR, IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA ACROSS THREE SEPARATE PHASE 1 STUDIES Free
Steven N. Kalkanis and others
Neuro-Oncology, Volume 17, Issue suppl_5, November 2015, Page v74, https://doi.org/10.1093/neuonc/nov212.06
Published: 09 November 2015
Journal Article
SURG-09RESULTS OF A DOSE ESCALATION TRIAL OF TOCA 511 WITH TOCA FC IN RECURRENT HGG UNDERGOING REPEAT RESECTION Free
Michael A. Vogelbaum and others
Neuro-Oncology, Volume 17, Issue suppl_5, November 2015, Page v216, https://doi.org/10.1093/neuonc/nov235.09
Published: 09 November 2015
Journal Article
AT-02INTRATUMORAL DELIVERY OF THE RETROVIRAL REPLICATING VECTOR (RRV) TOCA 511 IN SUBJECTS WITH RECURRENT HIGH GRADE GLIOMA: INTERIM REPORT OF PHASE 1 STUDY (NCT 01156584)
Get access
Manish Aghi and others
Neuro-Oncology, Volume 16, Issue suppl_5, November 2014, Page v8, https://doi.org/10.1093/neuonc/nou237.2
Published: 01 November 2014
Journal Article
IT-05ADMINISTRATION OF TOCA 511 TO SUBJECTS WITH RECURRENT HGG UNDERGOING REPEAT RESECTION
Get access
Timothy F. Cloughesy and others
Neuro-Oncology, Volume 16, Issue suppl_5, November 2014, Pages v110–v111, https://doi.org/10.1093/neuonc/nou258.4
Published: 01 November 2014
Journal Article
miR-181d: a predictive glioblastoma biomarker that downregulates MGMT expression
Get access
Wei Zhang and others
Neuro-Oncology, Volume 14, Issue 6, June 2012, Pages 712–719, https://doi.org/10.1093/neuonc/nos089
Published: 08 May 2012
Advertisement
Advertisement